These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 2368389)
1. [Comparison of the value of the glucagon test and galactose tolerance test in the clinical diagnosis of cirrhosis]. Poniewierka E Wiad Lek; 1990 Feb 1-15; 43(3-4):107-13. PubMed ID: 2368389 [TBL] [Abstract][Full Text] [Related]
2. Pancreatic glucoregulatory hormones in cirrhosis of the liver: portal vein concentrations during intravenous glucose tolerance test and in response to a meal. Holst JJ; Burcharth F; Kühl C Diabete Metab; 1980 Jun; 6(2):117-27. PubMed ID: 6997101 [TBL] [Abstract][Full Text] [Related]
3. [Significance of glucagon test in liver cirrhosis]. Kurochka Iu; Shpaniar E; Levchik A; Zagradni V; Golan I Klin Med (Mosk); 1977 Nov; 55(11):73-6. PubMed ID: 606995 [No Abstract] [Full Text] [Related]
4. Glucagon-induced alterations of plasma levels of cyclic AMP and glucose in patients with liver disease. Klotz U; Antonin KH Z Gastroenterol; 1984 Mar; 22(3):147-52. PubMed ID: 6326401 [TBL] [Abstract][Full Text] [Related]
5. [Comparative evaluation of tolerance tests with sulfobromophthalein and with galactose in chronic liver diseases. (Value and limitations of the discriminating analyses used in the 2 tests for diagnosis of hepatic cirrhosis)]. Coltorti M; Di Simone A; Budillon G; Carrella M; Oriani G Policlinico Med; 1968; 75(4):189-215. PubMed ID: 5708459 [No Abstract] [Full Text] [Related]
6. An intravenous galactose tolerance test with an enzymatic determination of galactose. A comparison with other diagnostic aids in hepatobiliary diseases. Tengström B Scand J Clin Lab Invest Suppl; 1966; 18():132-42. PubMed ID: 5958513 [No Abstract] [Full Text] [Related]
7. [The role of the serum BG(P-B) value from glucagon loading test in assessing liver function of cirrhosis patients]. Wu BF; Lin LL; Hu PJ Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):186. PubMed ID: 12681076 [No Abstract] [Full Text] [Related]
8. [Oral glucose tolerance test and glucagon loading test as useful parameters for evaluating liver functional reserve]. Lu MD Zhonghua Wai Ke Za Zhi; 1993 Sep; 31(9):532-5. PubMed ID: 8033715 [TBL] [Abstract][Full Text] [Related]
9. Carbohydrate metabolism in alcohol-induced fatty liver. Evidence for an abnormal insulin response to glucagon in alcoholic liver disease. Rehfeld JF; Juhl E; Hilden M Gastroenterology; 1973 Mar; 64(3):445-51. PubMed ID: 4691595 [No Abstract] [Full Text] [Related]
10. A comparison of the bromsulphthalein and galactose elimination test in patients with either chronic bowel inflammation or alcoholic liver disease. Nilsson LH; Hultman E Scand J Gastroenterol; 1974; 9(3):319-23. PubMed ID: 4850181 [No Abstract] [Full Text] [Related]
11. [Intravenous galactose-tolerance test in liver cirrhosis. A comparison with bromsulfalein leading]. Järnerot G Nord Med; 1970 Dec; 84(50):1586-8. PubMed ID: 5519422 [No Abstract] [Full Text] [Related]
12. Alterations in glucose metabolism associated with liver cirrhosis persist in the clinically stable long-term course after liver transplantation. Tietge UJ; Selberg O; Kreter A; Bahr MJ; Pirlich M; Burchert W; Müller MJ; Manns MP; Böker KH Liver Transpl; 2004 Aug; 10(8):1030-40. PubMed ID: 15390330 [TBL] [Abstract][Full Text] [Related]
13. [The cyclic AMP, insulin and glucose responses to glucagon stimulation in patients with liver cirrhosis according to the stage of development ]. Esteva Díaz F; Ducóns García J; Ceña Lázaro G; Márquez Galván M; Juste Rullo G; Barrao Comps F Rev Clin Esp; 1986 Nov; 179(7):347-51. PubMed ID: 3025944 [No Abstract] [Full Text] [Related]
14. [Glucagon-induced hyperglycemia as a measure of liver function]. Ege P; Jacobsen M Nord Med; 1971; 86(49):1475-7. PubMed ID: 5137026 [No Abstract] [Full Text] [Related]
15. Glucose, insulin and C-peptide release during a galactose tolerance test in alcoholic cirrhosis. Cavanna A; Avagnina P; Tappero R; Passarino G; Carta Q Quad Sclavo Diagn; 1983 Mar; 19(1):78-89. PubMed ID: 6371886 [No Abstract] [Full Text] [Related]
16. 13C-methacetin and 13C-galactose breath tests can assess restricted liver function even in early stages of primary biliary cirrhosis. Holtmeier J; Leuschner M; Schneider A; Leuschner U; Caspary WF; Braden B Scand J Gastroenterol; 2006 Nov; 41(11):1336-41. PubMed ID: 17060128 [TBL] [Abstract][Full Text] [Related]
17. The quantitative liver function as measured by the galactose elimination capacity. I. Diagnostic value and relations to clinical, biochemical, and histological findings in patients with steatosis and patients with cirrhosis. Lindskov J Acta Med Scand; 1982; 212(5):295-302. PubMed ID: 7180579 [TBL] [Abstract][Full Text] [Related]
18. [The value of the intravenous galactose tolerance test and serum vitamin B 12 level in the differential diagnosis and prognosis of liver diseases]. Hugod C; Gade S; Krasilnikoff A; Kristensen HP Ugeskr Laeger; 1975 Jan; 137(3):141-5. PubMed ID: 1136025 [No Abstract] [Full Text] [Related]
19. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test. Iwasaki Y; Kondo K; Hasegawa H; Oiso Y Diabetes Res; 1994; 25(3):129-37. PubMed ID: 7671552 [TBL] [Abstract][Full Text] [Related]
20. Pancreatic alpha- and beta-cell function and metabolic changes during oral L-alanine and glucose administration: comparative studies between normal, diabetic and cirrhotic subjects. Hattori T; Hotta N; Ohara K; Shinoda H; Kunieda T; Nomura T; Kakuta H; Tamagawa T; Sakamoto N Nagoya J Med Sci; 1989 Mar; 51(1-4):7-16. PubMed ID: 2671746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]